Healthcare

Research Antibodies and Reagents Market Growth Trajectory Through 2024-2033|Thermo Fisher Scientific Inc., Abcam plc, Cell Signaling Technology, Inc., Merck KGaA, Santa Cruz Biotechnology, Inc.

Scientific covid-19 virus antibody sample in laboratory research experiment biotech make cultivate vaccine against virus. Scientist look at microscope, science test tube analyse Chemistry laboratory

The Research Antibodies and Reagents by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Research Antibodies and Reagents Market:
https://www.thebusinessresearchcompany.com/report/research-antibodie-and-reagent-global-market-report

According to The Business Research Company’s Research Antibodies and Reagents, The research antibodies and reagents market size has grown strongly in recent years. It will grow from $15.19 billion in 2023 to $16.44 billion in 2024 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to increase in pharmaceutical r&d expenditure, increased geriatric population, increased healthcare expenditure, increase in government funds for research and growth in the number of healthcare facilities.

The research antibodies and reagents market size is expected to see strong growth in the next few years. It will grow to $24.04 billion in 2028 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to the increasing geriatric population, increasing prevalence of cancer and chronic diseases, increasing research and development spending, rise in healthcare expenditure, increasing financing for proteomics ventures, rising requirement for customized medicine and emergence of infectious diseases. Major trends in the forecast period include focusing on considering nanotechnology for identifying low-abundant molecules, launching innovative technological products to improve sales and profitability, focus on using advanced antibody purification technologies, consider acquiring and merging with other research agencies and centers and investing in r&d labs and initiatives..

Increasing investment in medical and health research and development (R&D) is predicted to contribute to the growth of the research antibodies and reagents market. In the field of life science research, antibodies and reagents are essential components for the investigation of biological processes or causes of diseases through careful experimentation, observation, laboratory work, analysis, and testing. For instance, in April 2021, according to a report published by the Congressional Budget Office, a US-based government agency that provides budget and economic information, pharmaceutical companies will have invested $83 billion on research and development activities around the world. Thus, increasing investment in healthcare research and development will increase the utilization of the research antibodies and reagents market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=3418&type=smp

The research antibodies and reagents market covered in this report is segmented –

1) By Technology: Western Blot, Immunofluorescence, Immunohistochemistry, Flow Cytometry, Enzyme-Linked Immunosorbent Assay (Elisa), Others
2) By Application: Proteomics, Genomics, Other Applications
3) By End User: Pharmaceutical & Biotechnology Industry, Academic & Research Institutes, Contract Research Organizations (CROs)

Technological advancements in the area of purification of antibodies and reagents show opportunities for the growth of the research antibodies and reagents market during the forecast period. Irreproducible antibodies and reagents are a major challenge for the industry, as this will affect the outcome of the research. For instance, in April 2021, Native Antigen Company, a UK-based developer and manufacturer of antigens and antibodies, launched a SARS-CoV-2 Neutralisation Assay Development Kit, which includes all the necessary reagents for measuring Spike-antibody binding. The kit is specifically designed for the identification and qualitative measurement of neutralizing antibodies, with a focus on the RBD-ACE2 interaction.

The research antibodies and reagents market report table of contents includes: